What is the address of Apotheek Jorissen?

The registered office of Apotheek Jorissen is located at Tongersesteenweg 47B, 3730 Bilzen-Hoeselt.

Is Apotheek Jorissen still active?

Yes. According to the CBE (30 October 2026) Apotheek Jorissen is active, legal situation “Normale toestand”, started on 13 November 1979.

Is Apotheek Jorissen registered on Peppol?

Yes, Apotheek Jorissen is registered on the Peppol network with ID 0208:0419890828.

What is the enterprise number of Apotheek Jorissen?

The enterprise number of Apotheek Jorissen is BE0419890828.

When was Apotheek Jorissen founded?

Apotheek Jorissen was founded on 13 November 1979.

Who are the directors of Apotheek Jorissen?

According to the 2025 annual accounts, the directors of Apotheek Jorissen are: Jean Louis Jorissen, Sonja Scherpenberg.

Is Apotheek Jorissen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 November 1979; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek Jorissen make in 2025?

Apotheek Jorissen recorded a loss after taxes of € 19,645 in financial year 2025.

What is the revenue of Apotheek Jorissen?

As a small company, Apotheek Jorissen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 30,641.

How much does an employee at Apotheek Jorissen earn?

The average wage cost per full-time employee at Apotheek Jorissen was € 45,500 in 2023: staff costs of € 204,876 for 4.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Jorissen have?

According to the 2025 annual accounts, Apotheek Jorissen has 0 full-time equivalents (FTE).

Apotheek Jorissen (Public Limited) - Bilzen-Hoeselt

Dossier Apotheek Jorissen, printed on 30 October 2026 from databakkes.be/en/0419890828/apotheek-jorissen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Jorissen from Bilzen-Hoeselt, company number BE0419890828, closed financial year 2025 with a result of € -19,645 after tax. For that financial year Apotheek Jorissen recorded a gross margin of € 30,641 and equity of € 877,429. Compared with financial year 2024, the result moved from € 59,019 to € -19,645. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Healthy

€ 877,429

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -19,645

▼ still € 59,019 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,890

▼ 76% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 772,075.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 5,125

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 453,698

▼ 8% vs 2024

€ 36,618 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 18,355

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 393

▼ € 103,819 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 398,191 Gross margin 2022: € 398,191 First fiscal year in the series	€ 323,597 Gross margin 2023: € 323,597 ▼ 19% vs 2022 (€ 398,191) Unfavourable step	€ 264,767 Gross margin 2024: € 264,767 ▼ 18% vs 2023 (€ 323,597) Unfavourable step	€ 30,641 Gross margin 2025: € 30,641 ▼ 88% vs 2024 (€ 264,767) Unfavourable step	▼ 88%
Profit after taxes	€ 157,225 Profit after taxes 2022: € 157,225 First fiscal year in the series	€ 24,148 Profit after taxes 2023: € 24,148 ▼ 85% vs 2022 (€ 157,225) Unfavourable step	€ 59,019 Profit after taxes 2024: € 59,019 ▲ 144% vs 2023 (€ 24,148) Favourable step	€ -19,645 Profit after taxes 2025: € -19,645 ▼ € 78,664 vs 2024 (€ 59,019) Unfavourable step	▼ € 78,664
Equity	€ 813,906 Equity 2022: € 813,906 First fiscal year in the series	€ 838,055 Equity 2023: € 838,055 ▲ 3% vs 2022 (€ 813,906) Favourable step	€ 897,074 Equity 2024: € 897,074 ▲ 7% vs 2023 (€ 838,055) Favourable step	€ 877,429 Equity 2025: € 877,429 ▼ 2% vs 2024 (€ 897,074) Unfavourable step	▼ 2%
Total debts	€ 609,115 Total debts 2022: € 609,115 First fiscal year in the series	€ 669,556 Total debts 2023: € 669,556 ▲ 10% vs 2022 (€ 609,115) Unfavourable step	€ 601,938 Total debts 2024: € 601,938 ▼ 10% vs 2023 (€ 669,556) Favourable step	€ 476,780 Total debts 2025: € 476,780 ▼ 21% vs 2024 (€ 601,938) Favourable step	▼ 21%
Cash	€ 98,956 Cash 2022: € 98,956 First fiscal year in the series	€ 133,076 Cash 2023: € 133,076 ▲ 34% vs 2022 (€ 98,956) Favourable step	€ 143,235 Cash 2024: € 143,235 ▲ 8% vs 2023 (€ 133,076) Favourable step	€ 33,890 Cash 2025: € 33,890 ▼ 76% vs 2024 (€ 143,235) Unfavourable step	▼ 76%
Land & buildings	€ 101,432 Land & buildings 2022: € 101,432 First fiscal year in the series	€ 207,536 Land & buildings 2023: € 207,536 ▲ 105% vs 2022 (€ 101,432) Unchanged	€ 194,340 Land & buildings 2024: € 194,340 ▼ 6% vs 2023 (€ 207,536) Unchanged	€ 200,622 Land & buildings 2025: € 200,622 ▲ 3% vs 2024 (€ 194,340) Unchanged	▲ 3%
Retained profit	€ 708,552 Retained profit 2022: € 708,552 First fiscal year in the series	€ 732,700 Retained profit 2023: € 732,700 ▲ 3% vs 2022 (€ 708,552) Favourable step	€ 791,720 Retained profit 2024: € 791,720 ▲ 8% vs 2023 (€ 732,700) Favourable step	€ 772,075 Retained profit 2025: € 772,075 ▼ 2% vs 2024 (€ 791,720) Unfavourable step	▼ 2%
Bank debt	€ 352,153 Bank debt 2022: € 352,153 First fiscal year in the series	€ 537,231 Bank debt 2023: € 537,231 ▲ 53% vs 2022 (€ 352,153) Unfavourable step	€ 493,764 Bank debt 2024: € 493,764 ▼ 8% vs 2023 (€ 537,231) Favourable step	€ 453,698 Bank debt 2025: € 453,698 ▼ 8% vs 2024 (€ 493,764) Favourable step	▼ 8%
Balance sheet total	€ 1,423,021 Balance sheet total 2022: € 1,423,021 First fiscal year in the series	€ 1,507,611 Balance sheet total 2023: € 1,507,611 ▲ 6% vs 2022 (€ 1,423,021) Unchanged	€ 1,499,012 Balance sheet total 2024: € 1,499,012 ▼ 1% vs 2023 (€ 1,507,611) Unchanged	€ 1,354,210 Balance sheet total 2025: € 1,354,210 ▼ 10% vs 2024 (€ 1,499,012) Unchanged	▼ 10%
Employees (FTE)	3.5 Employees (FTE) 2022: 3.5 First fiscal year in the series	4.5 Employees (FTE) 2023: 4.5 ▲ 1 vs 2022 (3.5) Unchanged	0 Employees (FTE) 2024: 0 ▼ 4.5 vs 2023 (4.5) Unchanged	0 Employees (FTE) 2025: 0 Unchanged (0) Unchanged

Key figures of Apotheek Jorissen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Jorissen?

What happened at Apotheek Jorissen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Jean Louis Jorissen stepped down as director. NBB
2027 Sonja Scherpenberg stepped down as director. NBB
Jul 27, 2026 New annual accounts for financial year 2025: loss of € 19,645 (▼ € 78,664 vs 2024). Source: NBB ↗
2021 Jean Louis Jorissen became a director. NBB
2021 Sonja Scherpenberg became a director. NBB
Nov 13, 1979 New establishment in Bilzen-Hoeselt. KBO
Nov 13, 1979 Start of the company according to the CBE. KBO

In short

From € 157,225 profit in 2022 to € 19,645 loss in 2025.

Paid € 65,178 in corporate taxes since 2022.

Best year ever: 2022, with € 157,225 profit.

On average € 71,900 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Jean Louis Jorissen

Managing director

Also active at: COMED, REGI-O, COMED, APOTHEEK JORISSEN

since 2021 · until 2027

Sonja Scherpenberg

Managing director

Also active at: COMED, REGI-O, COMED, APOTHEEK JORISSEN

since 2021 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Tongersesteenweg 47B

3730 Bilzen-Hoeselt

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Jorissen-Scherpenberg

APOTHEEK JORISSEN same network

€ 353,559 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0419.890.828
VAT number: BE 0419.890.828
Registered office: Tongersesteenweg 47B, 3730 Bilzen-Hoeselt
Names & denominations: Apotheek Jorissen
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 13 November 1979
Peppol: Active · Active since 12 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Jorissen